Literature DB >> 26295821

Therapeutic Potential of Erythropoietin in Retinal and Optic Nerve Diseases.

Bekir Kucuk, Yakup Cevik, Ugur Acar, Gungor Sobaci1.   

Abstract

Recent studies have shown that, in addition to its well-known erythropoietic effects, erythropoietin has anti-inflammatory, neuroprotective, and neurotrophic effects in different tissues including the retina and optic nerve. In this review, we made a comprehensive search to define the therapeutic potential of erythropoietin in retinal and optic nerve diseases that lead to blindness.

Entities:  

Mesh：

Substances：

Year:  2015        PMID： 26295821     DOI： 10.2174/1871527314666150821104800

Source DB:  PubMed          Journal:  CNS Neurol Disord Drug Targets        ISSN： 1871-5273            Impact factor:   4.388


  4 in total

1.  Charting a course for erythropoietin in traumatic brain injury.

Authors:  Kenneth Maiese
Journal:  J Transl Sci       Date:  2016-03-26

2.  Intravitreal erythropoietin injection in late-stage optic neuropathy: a safety study on human.

Authors:  Ugur Acar; Bekir Kucuk; Mehmet Koray Sevinc; Seckin Aykas; Mesut Erdurmus; Gungor Sobaci
Journal:  Int Ophthalmol       Date:  2017-05-19       Impact factor: 2.031

3.  Mechanism of erythropoietin-induced M2 microglia polarization via Akt / Mtor / P70S6k signaling pathway in the treatment of brain injury in premature mice and its effect on biofilm.

Authors:  Xiuling Wu; Bo Wang; Qiling Ma; Yunfang Zhang; Ji Xu; Zhongyuan Zhang; Guangfu Chen
Journal:  Bioengineered       Date:  2022-05       Impact factor: 6.832

4.  Visual-Evoked-Response-Supported Outcome of Intravitreal Erythropoietin in Management of Indirect Traumatic Optic Neuropathy.

Authors:  Mohammad Ahmad Rashad; Ahmed Abdel Meguid Abdel Latif; Hazem A Mostafa; Samah Mahmoud Fawzy; Mahmoud Abdel Meguid Abdel Latif
Journal:  J Ophthalmol       Date:  2018-12-16       Impact factor: 1.909
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.